Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma

International Journal of Biological Markers

Volumn 25, Issue 2, 2010, Pages 112-115

  Paule, Bernard ^a,b   Deslandes, Emmanuelle ^c   Le Mouel, Stéphane E ^b   Bastien, Laurence ^b   Podgorniak, Marie Pierre ^d   Allory, Yves ^b   De La Taille, Alexandre ^b   Menashi, Suzanne ^e   Calvo, Fabien ^a,c,d   Mourah, Samia ^a,c,d  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Angiogenesis; Biomarkers; Bone metastasis; Invasion; RCC

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LYMPHATIC VESSEL ENDOTHELIAL RECEPTOR 1; MEMBRANE RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RNA; SUNITINIB; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE METASTASIS; CANCER CENTER; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER TISSUE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY CLEAR CELL CARCINOMA; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION; TREATMENT RESPONSE; BONE NEOPLASMS; CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; ISOLATION AND PURIFICATION; KIDNEY NEOPLASMS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY;

AGED; BONE NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954890420     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500209     Document Type: Article

References (11)

1. Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008; 34: 193-205.
2. Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol 1991; 9: 509-24.
3. Motzer RJ, Bacik J, Schwartz LH, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004; 22: 454-63. (Pubitemid 41079774)
4. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-8. (Pubitemid 29289424)
5. Yang Q, McHugh KP, Patntirapong S, Gu X, Wunderlich L, Hauschka PV. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 2008; 27: 589-99.
6. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 1997; 3: 1222-7. (Pubitemid 27508822)
7. Yoshimura I, Mizuguchi Y, Miyajima A, Asano T, Tadakuma T, Hayakawa M. Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor I. J Urol 2004; 171: 2467-70. (Pubitemid 38625516)
8. Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res 2007; 67: 4157-63. (Pubitemid 46815061)
9. Liao D, Corle C, Seagroves TN, Johnson RS. Hypoxiainducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 2007; 67: 563-72.
10. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD. Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A 1993; 90: 5021-5.
11. Dong Z, Saliganan AD, Meng H, et al. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. Neoplasia 2008; 10: 439-49.